Colinz Laboratories Limited (BSE: 531210)
Health Care · Pharmaceuticals · IN
Rs74.20
-7.10% today · +79.2% 1Y
Colinz Laboratories Limited (BSE: 531210) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.95M.
Over the last twelve months the share price has gained 79.2%, trading between 36.11 and 87.91.
Tweenvest scores Colinz Laboratories Limited across four factors: quality 78/100, value 44/100, growth 22/100. Its strongest factor is quality.
531210 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.95M
- Revenue (TTM)
- $614.57K
- P/E
- 6.68
- EPS
- 11.11
- Dividend yield
- —
- Beta (5Y)
- -0.07
- 52-week high
- Rs87.91
- 52-week low
- Rs36.11
- Avg volume (3M)
- —
- Shares outstanding
- 2.52M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,235.35 | +0.14% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.38 | +0.09% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.17 | -0.18% |
| Roche Holding AGSWX: ROP | $371.62B | CHF374.20 | +0.11% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.68 | -0.87% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.51 | -0.21% |
Figures last refreshed Aug 18, 2026.